Tax included.
The Pharma Legal Handbook: Asia contains 8 comprehensive country legal guides and answers essential questions about the legal and regulatory environment for pharmaceutical companies in Asia. It is a must-have for any company operating in the continent or looking to enter the market.
Countries featured:
China, India, Indonesia, Japan, Malaysia, Singapore, Thailand & Vietnam
Prepared in association with some of the continent's leading law firms, The Pharma Legal Handbook: Asia should answer any questions linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents, cannabinoid medicines, medical cannabis and opioid drugs.
Publisher: White Publishing Resources
The Pharma Legal Handbook: Asia consists of a zipped folder containing 8 individual Pharma Legal Handbook PDF files (contributing legal partners in parenthesis):
China (Fangda)
India (Nishith Desai)
Indonesia (ABNR)
Japan (Nishimura Asahi)
Malaysia (Skrine)
Singapore (Drew & Napier)
Thailand (Tilleke & Gibbins)
Vietnam (Tilleke & Gibbins)
Publication Date: March 2020
Last Update: March 2024
China
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
India
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Indonesia
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Localization
Japan
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
Malaysia
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
Singapore
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Thailand
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms
- Cannabinoid Drugs
- Medical Cannabis
- Opioid Drugs
- Orphan Drugs & Rare Diseases
- Localization
- Biosimilars & Biologics
Vietnam
- Regulatory, Pricing, and Reimbursement Overview
- Preclinical & Clinical Trial Requirements
- Marketing, Manufacturing, Packaging & Labeling, Advertising
- Traditional Medicines & OTC Products
- Product Liability
- Patents & Trademarks
- Regulatory Reforms